{"log_id": 5707391808767248223, "direction": 0, "words_result_num": 41, "words_result": [{"probability": {"variance": 0.002982, "average": 0.951596, "min": 0.860977}, "location": {"width": 144, "top": 294, "height": 34, "left": 281}, "words": "注意项】"}, {"probability": {"variance": 0.029808, "average": 0.878988, "min": 0.539649}, "location": {"width": 164, "top": 358, "height": 36, "left": 272}, "words": "药物相作用"}, {"probability": {"variance": 0.016634, "average": 0.942294, "min": 0.443024}, "location": {"width": 1108, "top": 489, "height": 43, "left": 322}, "words": "恩曲他滨香诺福韦与去羟肌苷联合给药时应当谨慎,受联合用药的患者应当密切监测与去羟"}, {"probability": {"variance": 0.019899, "average": 0.914406, "min": 0.498889}, "location": {"width": 1026, "top": 525, "height": 38, "left": 267}, "words": "肌苷有关的不反应,在出现与去羟肌相关的不良反应的患者中,应当停用去羟肌昔"}, {"probability": {"variance": 0.025829, "average": 0.902569, "min": 0.417886}, "location": {"width": 1102, "top": 592, "height": 41, "left": 324}, "words": "与富马酸替话福韦二吡酯联合给药时,去羟肌苷缓释片或肠溶制剂的最大血清浓度(C)和"}, {"probability": {"variance": 0.019544, "average": 0.928157, "min": 0.391474}, "location": {"width": 1143, "top": 626, "height": 38, "left": 269}, "words": "血浆浓度时间曲线下面积(ALC)显著升高(见【药代动力学】)这种相互作用的机制尚明"}, {"probability": {"variance": 0.01503, "average": 0.94306, "min": 0.502594}, "location": {"width": 1159, "top": 660, "height": 45, "left": 265}, "words": "确。高的去羟肌苷浓度有可能导致与去羟肌苷有关的不良反应,包括炎和神经病变,在接受"}, {"probability": {"variance": 0.02036, "average": 0.927208, "min": 0.375456}, "location": {"width": 1010, "top": 699, "height": 34, "left": 265}, "words": "富马酸替诺福二呋和去羟肌苷每大400mg的患者中,观察到CD4细胞计数下降"}, {"probability": {"variance": 0.021781, "average": 0.902635, "min": 0.503987}, "location": {"width": 1092, "top": 761, "height": 45, "left": 317}, "words": "在休重>60kg的患者中,与思由他滨替诺福联用时,去羟肌苷的剂量应当减至250mg在"}, {"probability": {"variance": 0.022359, "average": 0.9165, "min": 0.410181}, "location": {"width": 1159, "top": 797, "height": 43, "left": 262}, "words": "体重<E0kg的成人或儿童老中,日前还没有大羟肌剂量调整建议的数据联合给药时,恩由他"}, {"probability": {"variance": 0.00911, "average": 0.962455, "min": 0.560991}, "location": {"width": 845, "top": 834, "height": 34, "left": 262}, "words": "滨替诺福韦和去羟肌苷肠溶剂可以在空腹状态下或与清淡食物(<400K"}, {"probability": {"variance": 0.000761, "average": 0.980906, "min": 0.903393}, "location": {"width": 233, "top": 841, "height": 32, "left": 1170}, "words": "20%脂肪)同时给药"}, {"probability": {"variance": 0.009758, "average": 0.948122, "min": 0.570033}, "location": {"width": 754, "top": 868, "height": 36, "left": 262}, "words": "去羟肌苷缓释片与恩曲性滨替诺福韦应当在空腹状态下联合给药"}, {"probability": {"variance": 0.000537, "average": 0.983413, "min": 0.943533}, "location": {"width": 112, "top": 932, "height": 34, "left": 258}, "words": "阿扎那韦"}, {"probability": {"variance": 0.017819, "average": 0.925848, "min": 0.366961}, "location": {"width": 640, "top": 996, "height": 41, "left": 310}, "words": "阿扎那韦可使替诺福韦浓度增加,见【药代动力学"}, {"probability": {"variance": 0.02509, "average": 0.927595, "min": 0.509254}, "location": {"width": 406, "top": 1005, "height": 34, "left": 1008}, "words": "这种相互作用的机制尚未明确:在"}, {"probability": {"variance": 0.015929, "average": 0.934924, "min": 0.514613}, "location": {"width": 1156, "top": 1031, "height": 50, "left": 258}, "words": "接受阿扎那书和恩曲他滨替诺福韦的患者中,应当监测其与恩曲他滨替诺福韦相关的不良反应。在"}, {"probability": {"variance": 0.013077, "average": 0.947684, "min": 0.454585}, "location": {"width": 944, "top": 1069, "height": 41, "left": 260}, "words": "出现与恩曲他滨替诺福韦相关的不良反应的患者中,应当停用恩曲他滨替诺福韦"}, {"probability": {"variance": 0.033639, "average": 0.885941, "min": 0.400925}, "location": {"width": 1106, "top": 1136, "height": 41, "left": 306}, "words": "替诸福韦降低阿扎的ALC和Cimt参见【药代动力学】),与曲他滨诺福韦合用时,建"}, {"probability": {"variance": 0.024634, "average": 0.892959, "min": 0.402674}, "location": {"width": 1156, "top": 1170, "height": 45, "left": 256}, "words": "议阿扎那书300mg与利托那韦100mg同时给药。如果没有利托那韦,阿扎那不应与恩曲他滨替诺"}, {"probability": {"variance": 0.021033, "average": 0.872857, "min": 0.605617}, "location": {"width": 162, "top": 1209, "height": 29, "left": 256}, "words": "福韦联合给药"}, {"probability": {"variance": 0.033174, "average": 0.899286, "min": 0.413756}, "location": {"width": 233, "top": 1273, "height": 32, "left": 251}, "words": "洛匹那/利托那韦"}, {"probability": {"variance": 0.012414, "average": 0.941053, "min": 0.508357}, "location": {"width": 1095, "top": 1335, "height": 45, "left": 304}, "words": "洛匹那韦/托那书可使替诺福韦浓度增(参见【药代动力学】)。这种相互作用的机制尚"}, {"probability": {"variance": 0.021117, "average": 0.911203, "min": 0.438072}, "location": {"width": 1138, "top": 1371, "height": 45, "left": 251}, "words": "未明确。在接受洛匹那书/利托那韦和恩曲他滨替诺福书的患者中,应当监测其与恩曲他滨替诺"}, {"probability": {"variance": 0.019092, "average": 0.940221, "min": 0.366935}, "location": {"width": 1156, "top": 1406, "height": 45, "left": 251}, "words": "韦相关的小真反应,在出现与由滨替诺福韦相关的不良反应的患者中,应当停用恩由他滨替诺"}, {"probability": {"variance": 0.015742, "average": 0.856599, "min": 0.731131}, "location": {"width": 52, "top": 1442, "height": 32, "left": 251}, "words": "福韦"}, {"probability": {"variance": 0.009219, "average": 0.930386, "min": 0.739542}, "location": {"width": 203, "top": 1502, "height": 41, "left": 251}, "words": "影肾功旅药"}, {"probability": {"variance": 0.031188, "average": 0.783423, "min": 0.606822}, "location": {"width": 116, "top": 1538, "height": 43, "left": 381}, "words": "地医"}, {"probability": {"variance": 0.04016, "average": 0.829072, "min": 0.481621}, "location": {"width": 224, "top": 1572, "height": 32, "left": 297}, "words": "恩出他滨和替诺楼"}, {"probability": {"variance": 0.01252, "average": 0.955173, "min": 0.576812}, "location": {"width": 807, "top": 1575, "height": 43, "left": 596}, "words": "通过肾小球过滤和肾小管主动清除结合的方式经肾脏清除〔参见【药"}, {"probability": {"variance": 2e-06, "average": 0.998485, "min": 0.996743}, "location": {"width": 118, "top": 1607, "height": 32, "left": 249}, "words": "代动力"}, {"probability": {"variance": 0.020025, "average": 0.940726, "min": 0.358628}, "location": {"width": 969, "top": 1609, "height": 43, "left": 432}, "words": "未观察到肾除竞争产生的药物相互作用。但是,恩曲他滨替诺福韦与通过肾小"}, {"probability": {"variance": 0.045193, "average": 0.860348, "min": 0.363536}, "location": {"width": 1150, "top": 1639, "height": 52, "left": 242}, "words": "管动清除的药物用教使曲他滨、替诺福韦机/或合井药物的浓度升高。此类药物包括但"}, {"probability": {"variance": 0.053312, "average": 0.785941, "min": 0.351593}, "location": {"width": 285, "top": 1678, "height": 34, "left": 249}, "words": "不于无环鸟背阿德行"}, {"probability": {"variance": 0.046614, "average": 0.848674, "min": 0.393854}, "location": {"width": 779, "top": 1678, "height": 48, "left": 617}, "words": "西多福韦,更洛韦、伐洛书和更普洛韦。能够降低肾功能的"}, {"probability": {"variance": 0.013656, "average": 0.922646, "min": 0.596487}, "location": {"width": 637, "top": 1712, "height": 38, "left": 242}, "words": "药物也有能增恩和/或诺福书的血清浓度"}, {"probability": {"variance": 0.000262, "average": 0.992078, "min": 0.9525}, "location": {"width": 212, "top": 1776, "height": 34, "left": 242}, "words": "骨矿物质密度下"}, {"probability": {"variance": 0.016814, "average": 0.903946, "min": 0.571046}, "location": {"width": 1065, "top": 1842, "height": 48, "left": 294}, "words": "在有病理性骨折或有骨质疏松或骨失风险的HTV-1感染成大和12岁(含)以上儿患者中"}, {"probability": {"variance": 0.016957, "average": 0.941252, "min": 0.457556}, "location": {"width": 1154, "top": 1877, "height": 50, "left": 240}, "words": "应当考志进行骨矿物质密度(BMD)评估。尽管没有对补充钙和维生素D的作用进行研究,但这样的"}, {"probability": {"variance": 0.010843, "average": 0.96352, "min": 0.487409}, "location": {"width": 834, "top": 1911, "height": 45, "left": 240}, "words": "补充可能对所有患者都有益,如果怀疑有骨异常。应当进行适当的会诊"}, {"probability": {"variance": 0.01357, "average": 0.815428, "min": 0.698937}, "location": {"width": 41, "top": 2137, "height": 34, "left": 1390}, "words": "19"}], "language": 3}